Enable Earlier Decision-Making in Cancer Prevention Trials

See how smarter endpoint strategies can reduce development risk and accelerate decision-making in oncology trials

Cancer prevention trials can take years to generate meaningful clinical outcomes, delaying critical development decisions. In this short video, Marc Buyse explains how IDDI helped enable earlier, data-driven decisions in a Lynch syndrome trial.

This case study illustrates how innovative trial design can help you:

  • Link early measurable endpoints to long-term cancer outcomes
  • Enable earlier, data-driven decisions during the trial
  • Reduce reliance on long-term endpoints such as cancer incidence
  • Maintain scientific and regulatory rigor throughout
  • Support more efficient and lower-risk trial designs

Explore Related Case Studies

Planning a cancer prevention or oncology trial?

Talk to our statistical experts about designing endpoints that accelerate decision-making while preserving rigor.

By submitting this form, you agree to receiving commercial electronic messages such as emails from IDDI. For more info, please visit our Privacy Policy. You can unsubscribe at any time by clicking the 'unsubscribe' button at the foot of any email communication from IDDI.